Cellular Immunotherapy Market Therapeutic Survey Reviews, Analysis 2021

The Global Cellular Immunotherapy Market Report provides a study with an in-depth overview, describing the product/industry scope and elaborating market outlook and status (2021-2030). The report is curated after in-depth research and analysis by experts. The report provides comprehensive valuable insights on the global Cellular Immunotherapy market development activities demonstrated by industry players, growth opportunities, and market sizing with analysis by key segments, leading and emerging players, and geographies.

The global cellular immunotherapy market is expected to grow from $2.74 billion in 2020 to $3.59 billion in 2021 at a compound annual growth rate (CAGR) of 31%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $6.73 billion in 2025 at a CAGR of 17%.

(Exclusive Offer: Flat 25% discount on this report)

Click the link to Get a Free Sample Copy of the Report:

https://www.marketinsightsreports.com/reports/08103166935/cellular-immunotherapy-global-market-report-2021-covid-19-growth-and-change-to-2030-including-1-by-therapy-tumour-infiltrating-lymphocyte-til-therapy-engineered-t-cell-receptor-tcr-therapy-chimeric-antigen-receptor-car-t-cell-therapy-natural-killer-nk-cell-therapy-2-by-primary-indication-b-cell-malignancies-prostate-cancer-renal-cell-carcinoma-liver-cancer-non-hodgkin-lymphoma-others-3-by-application-prostate-cancer-breast-cancer-skin-cancer-ovarian-cancer-brain-tumour-lung-cancer-others-covering-novartis-ag-gilead-sciences-inc-kite-pharma-apac-biotech-dendreon-pharmaceuticals-llc-jw-creagene-co-ltd/inquiry?mode=69

Top Companies in the Global Cellular Immunotherapy Market: Novartis AG; Gilead Sciences Inc. (Kite Pharma); Apac Biotech; Dendreon Pharmaceuticals LLC; JW CreaGene Co. Ltd; Green Cross Corp (GC Pharma); AstraZeneca; Bristol-Myers Squibb; Pfizer Inc.; Roche; Adicet Bio; ResTORbio; Celyad

Industry Updates:

In April 2020, resTORbio, Inc., a US-based biopharmaceutical company specialized in the development and commercialization of drugs used for the treatment of aging-related diseases, merged with Adicet Bio, Inc., a biopharmaceutical company, for an undisclosed amount. Both the companies continue their operations as Adicet Bio.

Market Overview:

The high cost of cellular immunotherapies is anticipated to hinder the cellular immunotherapys market growth. CAR-T therapy is a type of cellular immunotherapy and only two have been approved in the USA. The price of Yescarta and Kymriah is more than $350,000 per treatment in the USA, which is highly unaffordable for a majority of the patients especially with low income. The high cost of cellular immunotherapies discourages patients to opt for this drug, thereby, impacting the demand and the market negatively.

Companies in the cellular immunotherapy market are focusing on developing off-the-shelf allogeneic therapies for new and improved cancer treatment. Off-the-shelf allogeneic therapies are produced from the cells of donors instead of the patient cells as in the case of autologous therapy. Their non-customized nature provides advantages such as cost-effectiveness, large scale, fast, and quality control production. For instance, in November 2019, Precision Biosciences, Inc., a biotechnology company, has created a new generation allogeneic CAR-T therapy and is conducting an ongoing trial of this therapy by creating its first off-the-shelf allogeneic CAR-T therapy candidate known as PBCAR0191. This is in collaboration with Servier, an international pharmaceutical company, and is mainly for the patients in need of advanced cancer treatment options. Additionally, in August 2020, Acepodia, a US-based next-generation cell immuno-technology company, initiated a phase 1 clinical trial for evaluating ACE1702 an allogeneic, off-the-shelf NK cell therapy for the treatment of solid tumors.

Market Segmentation:

Markets Covered: 1) By Therapy: Tumour-Infiltrating Lymphocyte (TIL) Therapy; Engineered T Cell Receptor (TCR) Therapy; Chimeric Antigen Receptor (CAR) T Cell Therapy; Natural Killer (NK) Cell Therapy
2) By Primary Indication: B-cell Malignancies; Prostate Cancer; Renal Cell Carcinoma; Liver Cancer; Non-Hodgkin lymphoma; Others
3) By Application: Prostate Cancer; Breast Cancer; Skin Cancer; Ovarian Cancer; Brain Tumour; Lung Cancer; Others

Regional Analysis:

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Inquire for Discount:

https://www.marketinsightsreports.com/reports/08103166935/cellular-immunotherapy-global-market-report-2021-covid-19-growth-and-change-to-2030-including-1-by-therapy-tumour-infiltrating-lymphocyte-til-therapy-engineered-t-cell-receptor-tcr-therapy-chimeric-antigen-receptor-car-t-cell-therapy-natural-killer-nk-cell-therapy-2-by-primary-indication-b-cell-malignancies-prostate-cancer-renal-cell-carcinoma-liver-cancer-non-hodgkin-lymphoma-others-3-by-application-prostate-cancer-breast-cancer-skin-cancer-ovarian-cancer-brain-tumour-lung-cancer-others-covering-novartis-ag-gilead-sciences-inc-kite-pharma-apac-biotech-dendreon-pharmaceuticals-llc-jw-creagene-co-ltd/discount?mode=69

Key Reasons to Purchase:
 
- To gain insightful analyses of the market and have comprehensive understanding of the global Cellular Immunotherapy market and its commercial landscape.
 
- Assess the production processes, major issues, and solutions to mitigate the development risk.
 
- To understand the most affecting driving and restraining forces in the market and its impact in the global market.
 
- Learn about the market strategies that are being adopted by leading respective organizations.
 
- To understand the future outlook and prospects for the Cellular Immunotherapy market.

Purchase Full Report@:

https://www.marketinsightsreports.com/report/purchase/08103166935?mode=su?mode=69

We Also Offer Customization on report based on specific client Requirement:

-Free country Level analysis for any 5 countries of your choice.

-Free Competitive analysis of any 5 key market players.

-Free 40 analyst hours to cover any other data point.

Please contact our sales professional (sales@marketinsightsreports.com), we will ensure you obtain the report which works for your needs.

Contact Us:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

About Us

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.